Nathan H. Fowler MDProfessor of Medicine, Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas
Nathan H Fowler, MD, is a Professor of Medicine in the Department of Lymphoma and Myeloma, Division of Cancer Medicine, at the University of Texas MD Anderson Cancer Center in Houston, Texas. He received his MD and completed his residency at the University of Texas before completing a clinical fellowship in hematology/oncology at Georgetown University where he was a chief fellow. Dr Fowler's interest in immunomodulatory agents began during his hematology/oncology fellowship at George University Hospital, where he helped develop some of the first protocols to use lenalidomide in chronic lymphocytic leukemia (CLL). His focus at MD Anderson has been the further development of novel therapeutic regimens with immunomodulatory therapies to help patients with low-grade non-Hodgkin lymphoma. Dr Fowler also serves as the chairman of several Phase I and investigator-initiated Phase II trials for patients with non-Hodgkin lymphoma.